On the same day, the board will also consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2021 along with a proposal for declaration of a second interim equity dividend for the financial year 2021-22.

The company recorded 56% growth in consolidated net profit to Rs 185 crore on a 7% rise in net sales to Rs 789 crore in Q2 FY22 over Q2 FY21.

Emami is one of India's leading FMCG companies engaged in manufacturing & marketing of personal care & healthcare products.